Progress in Mind Go to Progress in Mind Main channel featuring interviews, articles, congress highlights and much more. Go to channel
Migrän VideoExpert Views Key drivers of migraine disease progression At EAN 2022, Gisela Terwindt, Professor of Neurology, Leiden University Medical Centre, discussed... Content action menuShareTestTest 2Test 3
Migrän VideoExpert Views Challenges regarding impacts on daily function for people with migraine disease At EAN 2022, Cristina Tassorelli, Professor of Neurology, University of Pavia, Italy, discussed how... Content action menuShareTestTest 2Test 3
Mental health Lästid: 3 minut(s) Congress highlightsArticle How do psychiatric comorbidities affect migraine and its treatment? Patients with migraine often have psychiatric comorbidities. This can affect disease severity and... Content action menuShareTestTest 2Test 3
Migrän Lästid: 3 minut(s) Satellite symposium Experts discuss: how might we prevent migraine disease progression? In a satellite symposium at #WCN2021, three leading experts discussed recent insights into migraine... Content action menuShareTestTest 2Test 3
Alzheimers sjukdom Lästid: 6 minut(s) Article Alzheimer’s disease in 2021 & beyond – Where we are now Dementia prevalence, including that of Alzheimer’s disease, is set to rise greatly in the... Content action menuShareTestTest 2Test 3
Migrän Lästid: 4 minut(s) Congress highlights Why is migraine not just a bad headache? Recurrent incapacitating headaches accompanied by disorienting neurological symptoms prevents the... Content action menuShareTestTest 2Test 3
Depression, Schizofreni Lästid: 2 minut(s) Congress highlights Quarantines, lockdowns, and social isolation: What are we brewing? The COVID-19 pandemic continues to impact well-being across the globe. Lockdowns, quarantine, and... Content action menuShareTestTest 2Test 3
Migrän Lästid: 2 minut(s) Satellite symposium How does chronic migraine affect everyday life? The disabling headaches and symptoms of chronic migraine can impact almost every aspect of life.... Content action menuShareTestTest 2Test 3
Depression Lästid: 3 minut(s) Satellite symposium Optimizing early treatment central in reducing burden of resistant depression Treatment-resistant depression is associated with a high disease burden, functional impairment,... Content action menuShareTestTest 2Test 3
Schizofreni Lästid: 5 minut(s) Satellite symposium Treatment outcomes in schizophrenia – what matters to patients? Schizophrenia treatment has moved from mainly addressing relapse prevention and symptom suppression... Content action menuShareTestTest 2Test 3